PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

You don't 'own' your own genes

Researchers raise alarm about loss of individual 'genomic liberty' due to gene patents that may impact the era of personalized medicine

2013-03-26
(Press-News.org) NEW YORK (March 25, 2013) -- Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire human genome for profit, report two researchers who analyzed the patents on human DNA. Their study, published March 25 in the journal Genome Medicine, raises an alarm about the loss of individual "genomic liberty."

In their new analysis, the research team examined two types of patented DNA sequences: long and short fragments. They discovered that 41 percent of the human genome is covered by longer DNA patents that often cover whole genes. They also found that, because many genes share similar sequences within their genetic structure, if all of the "short sequence" patents were allowed in aggregate, they could account for 100 percent of the genome.

Furthermore, the study's lead author, Dr. Christopher E. Mason of Weill Cornell Medical College, and the study's co-author, Dr. Jeffrey Rosenfeld, an assistant professor of medicine at the University of Medicine & Dentistry of New Jersey and a member of the High Performance and Research Computing Group, found that short sequences from patents also cover virtually the entire genome -- even outside of genes.

"If these patents are enforced, our genomic liberty is lost," says Dr. Mason, an assistant professor of physiology and biophysics and computational genomics in computational biomedicine at the Institute for Computational Biomedicine at Weill Cornell. "Just as we enter the era of personalized medicine, we are ironically living in the most restrictive age of genomics. You have to ask, how is it possible that my doctor cannot look at my DNA without being concerned about patent infringement?"

The U.S. Supreme Court will review genomic patent rights in an upcoming hearing on April 15. At issue is the right of a molecular diagnostic company to claim patents not only on two key breast and ovarian cancer genes -- BRCA1 and BRCA2 -- but also on any small sequence of code within BRCA1, including a striking patent for only 15 nucleotides.

In its study, the research team matched small sequences within BRCA1 to other genes and found that just this one molecular diagnostic company's patents also covered at least 689 other human genes -- most of which have nothing to do with breast or ovarian cancer; rather, its patents cover 19 other cancers as well as genes involved in brain development and heart functioning.

"This means if the Supreme Court upholds the current scope of the patents, no physician or researcher can study the DNA of these genes from their patients, and no diagnostic test or drug can be developed based on any of these genes without infringing a patent," says Dr. Mason.

One Patented Sequence Matched More Than 91 Percent of Human Genes

Dr. Mason undertook the study because he realized that his research into brain and cancer disorders inevitably involved studying genes that were protected by patents.

Under U.S. patent law, genes can be patented by those researchers, either at companies or institutions, who are first to find a gene that promises a useful application, such as for a diagnostic test. For example, the patents received by a company in the 1990s on BRCA1 and BRCA2 enables it to offer a diagnostic test to women who may have, or may be at risk for, breast or ovarian cancer due to mutations in one or both of these genes. Women and their doctors have no choice but to use the services of the patents' owner, which costs $3,000 per test, "whereas any of the hundreds of clinical laboratories around the country could perform such a test for possibly much less," says Dr. Mason.

The impact on these patents is equally onerous on research, Dr. Mason adds.

"Almost every day, I come across a gene that is patented -- a situation that is common for every geneticist in every lab," says Dr. Mason. Dr. Mason and his research partner sought to determine how many other genes may be impacted by gene patents, as well as the overall landscape of intellectual property on the human genome.

To conduct the study, Dr. Mason and Dr. Rosenfeld examined the structure of the human genome in the context of two types of patented sequences: short and long fragments of DNA. They used matches to known genes that were confirmed to be present in patent claims, ranging from as few as 15 nucleotides (the building blocks of DNA) to the full length of all patented DNA fragments.

Before examining the patented sequences, the researchers first calculated how many genes had common segments of 15 nucleotide (15mer), and found that every gene in the human genome matched at least one other gene in this respect, ranging from as few as five matches 15mer to as many as 7,688 gene matches. They also discovered that 99.999 percent of 15mers in the human genome are repeated at least twice.

"This demonstrates that short patent sequences are extremely non-specific and that a 15mer claim from one gene will always cross-match and patent a portion of another gene as well," says Dr. Mason. "This means it is actually impossible to have a 15mer patent for just one gene."

Next, researchers examined the total sequence space in human genes covered by 15mers in current patent claims. They found 58 patents whose claims covered at least 10 percent of all bases of all human genes. The broadest patent claimed sequences that matched 91.5 percent of human genes. Then, when they took existing gene patents and matched patented 15mers to known genes, they discovered that 100 percent of known genes are patented.

"There is a real controversy regarding gene ownership due to the overlap of many competing patent claims. It is unclear who really owns the rights to any gene," says Dr. Rosenfeld. "While the Supreme Court is hearing one case concerning just the BRCA1 patent, there are also many other patents whose claims would cover those same genes. Do we need to go through every gene to look at who made the first claim to that gene, even if only one small part? If we resort to this rule, then the first patents to be granted for any DNA will have a vast claim over portions of the human genome."

A further issue of concern is that patents on DNA can readily cross species boundaries. A company can have a patent that they received for cow breeding and have that patent cover a large percentage of human genes. Indeed, the researchers found that one company owns the rights to 84 percent of all human genes for a patent they received for cow breeding. "It seems silly that a patent designed to study cow genetics also claims the majority of human genes," says Dr. Rosenfeld.

Finally, they also examined the impact of longer claimed DNA sequences from existing gene patents, which ranged from a few dozen bases up to thousands of bases of DNA, and found that these long, claimed sequences matched 41 percent (9,361) of human genes. Their analysis concluded that almost all clinically relevant genes have already been patented, especially for short sequence patents, showing all human genes are patented many times over.

"This is, so to speak, patently ridiculous," adds Dr. Mason. "If patent claims that use these small DNA sequences are upheld, it could potentially create a situation where a piece of every gene in the human genome is patented by a phalanx of competing patents."

In their discussion, the researchers argue that the U.S. Supreme Court now has a chance to shape the balance between the medical good versus inventor protection, adding that, in their opinion, the court should limit the patenting of existing nucleotide sequences, due to their broad scope and non-specificity in the human genome.

"I am extremely pro-patent, but I simply believe that people should not be able to patent a product of nature," Dr. Mason says. "Moreover, I believe that individuals have an innate right to their own genome, or to allow their doctor to look at that genome, just like the lungs or kidneys. Failure to resolve these ambiguities perpetuates a direct threat to genomic liberty, or the right to one's own DNA."

### Weill Cornell Medical College Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances -- including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with the Methodist Hospital in Houston. For more information, visit weill.cornell.edu.

University of Medicine and Dentistry of New Jersey The University of Medicine and Dentistry of New Jersey (UMDNJ) is New Jersey's only health sciences university with more than 6,000 students on five campuses attending three medical schools, the State's only dental school, a graduate school of biomedical sciences, a school of health related professions, a school of nursing and New Jersey's only school of public health. UMDNJ operates University Hospital, a Level I Trauma Center in Newark, and University Behavioral HealthCare, which provides a continuum of health care services with multiple locations throughout the state.


ELSE PRESS RELEASES FROM THIS DATE:

Women make better decisions than men

2013-03-26
Hamilton, ON, March 25, 2013 – Women's abilities to make fair decisions when competing interests are at stake make them better corporate leaders, researchers have found. A survey of more than 600 board directors showed that women are more likely to consider the rights of others and to take a cooperative approach to decision-making. This approach translates into better performance for their companies. The study, which was published this week in the International Journal of Business Governance and Ethics, was conducted by Chris Bart, professor of strategic management ...

Gene therapy may aid failing hearts

2013-03-26
In an animal study, researchers at the University of Washington show that it was possible to use gene therapy to boost heart muscle function. The finding suggests that it might be possible to use this approach to treat patients whose hearts have been weakened by heart attacks and other heart conditions. Led by University of Washington (UW) Professor and Vice Chair of Bioengineering Michael Regnier and Dr. Chuck Murry, director of the Center for Cardiovascular Biology and co-director of the Institute for Stem Cell and Regenerative Medicine at UW, the study appears online ...

Auto accidents often occur on low-speed roads, but a high-speed trip encourages reluctant bucklers

2013-03-26
Since most driving is done locally, it is not surprising that most auto accidents occur during routine errands. Yet, occasional seatbelt users are more likely to buckle up for trips on high-speed roads and less likely to use the belts for local driving, according to an analysis of data from 100 instrumented vehicles reported in the January issue of Accident Analysis and Prevention. If drivers and front-seat passengers used seatbelts all the time, deaths from crashes would be reduced by 45 percent, according to the National Highway Traffic Safety Administration (NHTSA). ...

Compounds found that alter cell signaling, could lead to new breast cancer treatments

2013-03-26
JUPITER, FL, March 25, 2013 – Using a broad spectrum of analytical tools, scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a class of novel compounds that can alter cell signaling activity, resulting in a variety of responses including a strong anti-inflammatory effect. These findings could lead to new strategies for treating diseases such as breast cancer. The study, published this week in the journal Nature Chemical Biology, focuses on compounds that interact with the estrogen receptor-α, a therapeutic target in breast ...

The latest genomic studies of wheat sheds new light on crop adaptation and domestication

2013-03-26
March 25, 2013, Shenzhen, China – The advanced online publication version of Nature today presents two manuscripts that provide an unprecedented glimpse into the adaptation and domestication of wheat. These achievements are the results of joint efforts led by the Institute of Genetics and Developmental Biology (IGDB), Chinese Academy of Sciences, Chinese Academy of Agricultural Sciences (CAAS), and BGI. The two projects sequenced and analyzed two ancestral wheat genomes of Triticum urartu and Aegilops tauschii, respectively, throwing light on the biology of the world's ...

Ganetespib shows potency against ALK-positive lung cancer and overcomes crizotinib resistance

2013-03-26
PHILADELPHIA — A drug that indirectly impairs the function of several cancer-driving proteins, including anaplastic lymphoma kinase (ALK), may be an effective new treatment for patients with ALK--positive non-small cell lung cancer. The drug, ganetespib, may also be effective for treating patients who have become resistant to the only FDA-approved targeted therapy for this disease, crizotinib, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research. "Lung cancer, a leading cause of death, is no longer thought of as ...

Early-onset baldness in African-American men may be linked to prostate cancer

2013-03-26
PHILADELPHIA — Baldness was associated with an increased risk of prostate cancer among African-American men, and risk for advanced prostate cancer increased with younger age and type of baldness, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "We focused on African-American men because they are at high risk for developing prostate cancer and are more than twice as likely to die from prostate cancer than other groups in the United States," said Charnita Zeigler-Johnson, Ph.D., research ...

Radiosurgery for treating unruptured intracranial arteriovenous malformations

2013-03-26
Charlottesville, VA (March 26, 2013). Researchers at the University of Virginia (UVA) Health System recommend radiosurgery for treating unruptured arteriovenous malformations (AVMs), because the procedure has a reasonable benefit-to-risk profile. They base this recommendation on an evaluation of clinical and radiographic outcomes in 444 patients treated with radiosurgery for unruptured AVMs at their institution. Detailed findings in this single-institution patient cohort are reported and discussed in "Radiosurgery for patients with unruptured intracranial arteriovenous ...

Study finds strong genetic component to childhood obesity

2013-03-26
Previous research has shown that obesity runs in families, and twin studies suggest that this is largely due to genetic factors, with heritability estimates over 50%. 32 genes have been identified as risk factors for obesity but previous analyses suggest that these genes alone cannot fully explain the high level of heritability in childhood obesity, as together they explain only 2% of individual differences in childhood body weight. This has led to a problem of 'missing heritability'. In this study, researchers used a new method called Genome-wide Complex Trait Analysis ...

Research yields significant insights into a common form of autism

2013-03-26
Memphis, Tenn. (March 26, 2013) – Identifying and understanding the combination of factors that leads to autism is an ongoing scientific challenge. This developmental disorder appears in the first three years of life, and affects the brain's normal development of social and communication skills. Results from a study led by Larry T. Reiter, PhD, at the University of Tennessee Health Science Center (UTHSC) are providing significant insights into the disorder through the study of a specific form of autism caused by a duplication on chromosome 15. This month his work appears ...

LAST 30 PRESS RELEASES:

Development of next-generation one-component epoxy with high-temperature stability and flame retardancy

Scaling up neuromorphic computing for more efficient and effective AI everywhere and anytime

Make it worth Weyl: engineering the first semimetallic Weyl quantum crystal

Exercise improves brain function, possibly reducing dementia risk

Diamonds are forever—But not in nanodevices

School-based program for newcomer students boosts mental health, research shows

Adding bridges to stabilize quantum networks

Major uncertainties remain about impact of treatment for gender related distress

Likely 50-fold rise in prevalence of gender related distress from 2011-21 in England

US college graduates live an average of 11 years longer than those who never finish high school

Scientists predict what will be top of the crops in UK by 2080 due to climate change

Study: Physical function of patients at discharge linked to hospital readmission rates

7 schools awarded financial grants to fuel student well-being

NYU Tandon research to improve emergency responses in urban areas with support from NVIDIA

Marcus Freeman named 2024 Paul “Bear” Bryant Coach of the Year

How creating and playing terrific video games can accelerate the battle against cancer

Rooting for resistance: How soybeans tackle nematode invaders is no secret anymore

Beer helps grocery stores tap sales in other categories

New USF study: Surprisingly, pulmonary fibrosis patients with COVID-19 improve

In a landmark study, an NYBG scientist and colleagues find that reforestation stands out among plant-based climate-mitigation strategies as most beneficial for wildlife biodiversity

RSClin® Tool N+ gives more accurate estimates of recurrence risk and individual chemotherapy benefit in node-positive breast cancer

Terahertz pulses induce chirality in a non-chiral crystal

AI judged to be more compassionate than expert crisis responders: Study

Scale-up fabrication of perovskite quantum dots

Adverse childhood experiences influence potentially dangerous firearm-related behavior in adulthood

Bacteria found to eat forever chemicals — and even some of their toxic byproducts

London cabbies’ planning strategies could help inform future of AI

More acidic oceans may affect the sex of oysters

Transportation insecurity in Detroit and beyond

New tool enables phylogenomic analyses of entire genomes

[Press-News.org] You don't 'own' your own genes
Researchers raise alarm about loss of individual 'genomic liberty' due to gene patents that may impact the era of personalized medicine